Minafin’s Health Chemistry Division Welcomes New CEO, Olivier Ubrich
The Minafin Group has appointed Olivier Ubrich as CEO of its Health Chemistry division, which encompasses Minakem CDMO and Minakem Generics & New Therapies. Ubrich,…
The Minafin Group has appointed Olivier Ubrich as CEO of its Health Chemistry division, which encompasses Minakem CDMO and Minakem Generics & New Therapies. Ubrich,…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.